Thank you to our speakers, sponsors, and delegates who joined us in Boston, MA for the summit!
If you are interested in the 2024 event, please get in touch at
info@hansonwade.com

14th World ADC London
March 2024
London, UK

ADC Payload Summit
May 2024
Boston, MA

Optimizing ADC Process Development to Increase Conjugation Yield, Reduce Impurities & Deliver to Shortened Timeframes At Scale

Welcome to the Inaugural ADC Process Development Summit

As more ADCs progress to and through clinical development, manufacturing and process development challenges are acting as a bottleneck in delaying timeframes.

New in 2023 and as part of the World ADC Series, the first ADC Process Development Summit offered a technical discussion enabling you to overcome your most pressing challenges including optimizing conjugation yields, enhancing purification to remove drug substance impurities, increasing efficiency and productivity to deliver on shortened timeframes, and
creating a robust regulatory strategy.

With 18 speakers from leading pharma and biotechs across the ADC space, this was your opportunity to connect with those working in process development, bioconjugation, CMC, purification and more for a unique deep dive helping you establish processes that guarantee product quality at a commercial scale.

Brand New from 2023: Overcome the Major Challenges

Discover How to Fast Track Your ADC Process Development to Deliver on Accelerated Timelines

Attendees gained valuable insights from Merck & Co., AbbVie, Seagen and more on how you can enhance your productivity, achieve cGMP compliance, secure regulatory approvals and successfully scale up your ADC process development.

 

See the 2023 agenda here.

Optimize the Effectiveness of Your ADCs by Transforming Your Conjugation Processes to Ensure High Conjugation Yield

Attendees leveraged the expertise of Heidelberg Pharma Research in selecting optimal tools and equipment for manufacturing your ADCs, ensuring a robust and efficient production process that enhances the quality and yield of your bioconjugates.

See the 2023 agenda here.

Overcome Process Regulatory Submission Challenges & Create a Robust Regulatory Strategy 

Attendees learned from approved case studies with Janssen and AstraZeneca to enhance your understanding of regulatory requirements that can impact your manufacturing process and improve the likelihood of a successful ADC submission.

See the 2023 agenda here.

Your 2023 World-Class Speakers in the ADC Space:

34133 - Laurie Milnar (1)
34133 - Christian Lutz (1)
34133 - Sunny Zhang (1)
34133 - Daniel Milano (1)

Laurie Milnar
Principal Research Scientist
AbbVie

Christian Lutz
Director, Project Management, CMC
Heidelberg Pharma Research

Sunny Zhang
Senior Director, Pharmaceutical Development
ADC Therapeutics

Daniel Milano
Senior Director- Process Development
Immunogen

Abzena-Logo-RGB-002-2048x291
MicrosoftTeams-image
MicrosoftTeams-image (1)
Asymbio CN

Proud to be Part of the World ADC Series:

Designed to make sure ADC experts are up to date with industry's advancements, the World ADC Event Series unites 1,500+ experts in the field to provide valuable insights and connections to advance ADCs as a first-option treatment. From globally leading conferences to webinars and industry reports, whatever the information you need, the ADC Process Development Summit can offer you the insights you need to maximizing the therapeutic window of ADCs and help to bring safe and effective therapies to market faster.

world-adc
world-adc-2
Screenshot-2023-03-09-181258